Literature DB >> 3781940

The identification of Pseudomonas cepacia and its occurrence in clinical material.

B Holmes.   

Abstract

During the 19 year period ending December 1984, 4840 strains of Gram-negative non-fermentative bacteria were submitted to the National Collection of Type Cultures for identification. Of these, 195 strains (4.0% of the total) were identified as Pseudomonas cepacia which demonstrates both that the species is regularly encountered in clinical material in the UK and that several laboratories have experienced difficulty in identifying the organism. The sources from which the 195 strains were isolated are reported and also the characteristics by which the species may be recognized. The clinical significance of Ps. cepacia is reviewed, and the resistance of this species to disinfectants and antimicrobial agents commonly used to treat pseudomonas infections is discussed to underline the necessity for the precise identification of Ps. cepacia.

Entities:  

Mesh:

Year:  1986        PMID: 3781940     DOI: 10.1111/j.1365-2672.1986.tb04291.x

Source DB:  PubMed          Journal:  J Appl Bacteriol        ISSN: 0021-8847


  14 in total

1.  Evaluation of three oligonucleotide primer sets in PCR for the identification of Burkholderia cepacia and their differentiation from Burkholderia gladioli.

Authors:  F E Clode; M E Kaufmann; H Malnick; T L Pitt
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

2.  Exceptionally high representation of Burkholderia cepacia among B. cepacia complex isolates recovered from the major Portuguese cystic fibrosis center.

Authors:  Mónica V Cunha; Ana Pinto-de-Oliveira; Luís Meirinhos-Soares; Maria José Salgado; José Melo-Cristino; Susana Correia; Celeste Barreto; Isabel Sá-Correia
Journal:  J Clin Microbiol       Date:  2007-03-14       Impact factor: 5.948

3.  Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard?

Authors:  S L Butler; C J Doherty; J E Hughes; J W Nelson; J R Govan
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

4.  Effects of growth rate and nutrient limitation on virulence factor production in Burkholderia cepacia.

Authors:  D McKenney; D G Allison
Journal:  J Bacteriol       Date:  1995-07       Impact factor: 3.490

Review 5.  Twenty years of paradigm-breaking studies of taxonomy and symbiotic nitrogen fixation by beta-rhizobia, and indication of Brazil as a hotspot of Paraburkholderia diversity.

Authors:  Fabiane Paulitsch; Fabio Bueno Dos Reis; Mariangela Hungria
Journal:  Arch Microbiol       Date:  2021-07-10       Impact factor: 2.552

6.  Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR.

Authors:  A Bauernfeind; I Schneider; R Jungwirth; C Roller
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

7.  In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia.

Authors:  C Lewin; C Doherty; J Govan
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

8.  Influence of Pseudomonas aeruginosa exoproducts on virulence factor production in Burkholderia cepacia: evidence of interspecies communication.

Authors:  D McKenney; K E Brown; D G Allison
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

9.  Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients.

Authors:  A L Barth; T L Pitt
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

Review 10.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.